遗传病信号编排了质母细胞瘤恶性病变,并增强了temozolomide的反应

Yuanyuan Li1, Yuxin Qiu1, Wenqing Gao1

  • 1Shanghai Pudong Hospital and School of Life Sciences, State Key Laboratory of Genetics and Development of Complex Phenotypes, Shanghai Engineering Research Center of Industrial Microorganisms, Fudan University, Shanghai, China.

Cell death & disease
|December 22, 2025
PubMed
概括

升高的RIPK1蛋白驱动着质母细胞瘤的生长,并预测预后不佳. 激活程序性亡 (亡) 增强化疗,提供新的质瘤治疗策略.